Targeted drug delivery (TDD) Targeted drug delivery stands as a meticulous approach, directing medication accurately to afflicted cells or tissues, thereby amplifying their therapeutic impact while mitigating adverse effects on healthy cells or tissues [168, 169]
Insulin resistance, hyperinsulinemia and atherosclerosis: insights into pathophysiological aspects and future therapeutic prospects
Therefore, the user assumes full liability for all decisions made based on this information
In this chapter the severity of the elevated biomarkers in the kidney is explained as observed in human studies: ALT and AST (Abdo et al., 1986), MCP-1, IL-6, TNF-a, PAI-1, and resistin (Jansen et al., 2016
The cycling approach is conservative given the lack of long-term human injectable data